de la Taille A - Search Results

1

Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.

Abrate A, Lazzeri M, Lughezzani G, Buffi N, Bini V, Haese A, de la Taille A, McNicholas T, Redorta JP, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Freschi M, Guazzoni G. Abrate A, et al. Among authors: de la taille a. BJU Int. 2015 Apr;115(4):537-45. doi: 10.1111/bju.12907. BJU Int. 2015. PMID: 25130593

2

Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.

de la Taille A, Hayek OR, Buttyan R, Bagiella E, Burchardt M, Katz AE. de la Taille A, et al. BJU Int. 1999 Nov;84(7):845-50. doi: 10.1046/j.1464-410x.1999.00285.x. BJU Int. 1999. PMID: 10532984

3

Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.

De La Taille A, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA, Katz AE. De La Taille A, et al. BJU Int. 2000 Feb;85(3):281-6. doi: 10.1046/j.1464-410x.2000.00456.x. BJU Int. 2000. PMID: 10671882

4

Predictive factors of radiation therapy for patients with prostate specific antigen recurrence after radical prostatectomy.

de la Taille A, Flam TA, Thiounn N, Pontvert D, Saighi D, Zerbib M, Debré B. de la Taille A, et al. BJU Int. 2002 Dec;90(9):887-92. doi: 10.1046/j.1464-410x.2002.03055.x. BJU Int. 2002. PMID: 12460351

5

Intermittent androgen suppression in patients with prostate cancer.

De La Taille A, Zerbib M, Conquy S, Amsellem-Ouazana D, Thiounn N, Flam TA, Debré B. De La Taille A, et al. BJU Int. 2003 Jan;91(1):18-22. doi: 10.1046/j.1464-410x.2003.04015.x. BJU Int. 2003. PMID: 12614243

6

A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.

Cindolo L, de la Taille A, Messina G, Romis L, Abbou CC, Altieri V, Rodriguez A, Patard JJ. Cindolo L, et al. Among authors: de la taille a. BJU Int. 2003 Dec;92(9):901-5. doi: 10.1111/j.1464-410x.2003.04505.x. BJU Int. 2003. PMID: 14632843

7

Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer.

Vordos D, Paule B, Vacherot F, Allory Y, Salomon L, Hoznek A, Yiou R, Chopin D, Abbou CC, de la Taille A. Vordos D, et al. Among authors: de la taille a. BJU Int. 2004 Sep;94(4):524-7. doi: 10.1111/j.1464-4096.2004.04919.x. BJU Int. 2004. PMID: 15329105 Clinical Trial.

8

Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?

Celhay O, de la Taille A, Salomon L, Doré B, Irani J. Celhay O, et al. Among authors: de la taille a. BJU Int. 2007 May;99(5):1028-30. doi: 10.1111/j.1464-410X.2007.06752.x. Epub 2007 Feb 26. BJU Int. 2007. PMID: 17324221

9

The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy.

Rodriguez-Covarrubias F, Larre S, De La Taille A, Abbou CC, Salomon L. Rodriguez-Covarrubias F, et al. Among authors: de la taille a. BJU Int. 2008 Feb;101(3):305-7. doi: 10.1111/j.1464-410X.2007.07273.x. Epub 2007 Oct 17. BJU Int. 2008. PMID: 17941921

10

Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.

Gallina A, Chun FK, Suardi N, Eastham JA, Perrotte P, Graefen M, Hutterer G, Huland H, Klein EA, Reuther A, Montorsi F, Briganti A, Shariat SF, Roehrborn CG, de la Taille A, Salomon L, Karakiewicz PI. Gallina A, et al. Among authors: de la taille a. BJU Int. 2008 Jun;101(12):1513-8. doi: 10.1111/j.1464-410X.2008.07519.x. Epub 2008 Apr 16. BJU Int. 2008. PMID: 18422773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

590 results

Search Page